(1) Objective: Breast cancer is the most common cancer in women, and the incidence of the disease continues to increase. The issue of immediate breast reconstruction (IBR) in women with BRCA mutations and breast cancer is highly topical. This study is based on the long-term experience of our workplace with the diagnosis and treatment of breast cancer in women. We use the possibilities of oncoplastic surgery, including IBR. Our effort involves learning about women's awareness of IBR with a mastectomy at the same time. (2) Methods: The method of quantitative research of women's awareness using a structured anonymous questionnaire was chosen. Out of the total number of 84 respondents who already underwent IBR, 36.9% were due to BRCA mutations, and 63.1% were due to breast cancer. (3) Results: All of the respondents learned about the possibility of IBR before treatment or during treatment planning. The information was first obtained mainly from an oncologist. Women obtained the most information regarding IBR from a plastic surgeon. Before the mastectomy, all of the respondents already knew what IBR meant, as well as about the payment of IBR by the health insurance company. All of the respondents would choose the IBR option again. A total of 94.0% of women cited preservation of body integrity as a reason for undergoing IBR, and 88.1% of women knew about the possibility of performing IBR with their own tissues. (4) Conclusions: There are few specialized centers with a team of experts in reconstructive breast surgery in the Czech Republic, especially those that perform IBR. Research has shown that all of the patients were well informed about IBR, but the vast majority only learned about IBR before the surgical procedure was planned. All of the women wished to maintain body integrity. Our study results in the recommendations for patients and for healthcare management.

5 CLINIC Clinic of Plastic Aesthetic Surgery and Gynecology 603 00 Brno Czech Republic

Department of Internal Medicine Hematology and Oncology University Hospital Brno and Masaryk University 625 00 Brno Czech Republic

Department of Obstetrics and Gynecology University Hospital Brno and Masaryk University 625 00 Brno Czech Republic

Department of Surgery University Hospital Brno and Masaryk University 625 00 Brno Czech Republic

See more in PubMed

Arnold M., Morgan E., Rumgay H., Mafra A., Singh D., Laversanne M., Vignat J., Gralow J.R., Cardoso F., Siesling S., et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15–23. doi: 10.1016/j.breast.2022.08.010. PubMed DOI PMC

Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. PubMed DOI

Grogan Fleege N.M., Cobain E.F. Breast cancer management in 2021: A primer for the obstetrics and gynecology. Best. Pract. Res. Clin. Obstet. Gynaecol. 2022;82:30–45. doi: 10.1016/j.bpobgyn.2022.02.004. PubMed DOI

Krejčí D., Pehalová L., Talábová A., Pokorová K., Katinová I., Mužík J., Dušek L. Cancer Incidence in the Czech Republic 2018. Institute of Health Information and Statistics of the Czech Republic. [(accessed on 20 February 2023)]. Available online: https://www.uzis.cz/res/f/008352/novotvary2018.pdf.

Weinberger V., Minář L., Brančíková D. Modern surgical and biological therapy of breast cancer. Ceska Gynekol. 2012;77:513–520. PubMed

Halászová N., Crha I., Huser M., Weinberger V., Žáková J., Ješeta M., Lousová E., Filipínská E., Ventruba P. Fertility preserving methods in women with breast cancer before gonadotoxic therapy. Ceska Gynekol. 2017;82:287–292. PubMed

Chmelová K., Nováčková M. Effect of manual lymphatic drainage on upper limb lymphedema after surgery for breast cancer. Ceska Gynekol. 2022;87:317–323. doi: 10.48095/cccg2022317. PubMed DOI

Mlakar I., Lin S., Nateqi J., Gruarin S., Diéguez L., Piairo P., Pires L.R., Tement S., Aleksandraviča I., Leja M., et al. Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study. J. Clin. Med. 2022;11:2041. doi: 10.3390/jcm11072041. PubMed DOI PMC

Foretova L., Petrakova K., Palacova M., Kalabova R., Navratilova M., Lukesova M., Vasickova P., Machackova E., Kleibl Z., Pohlreich P. Genetic and preventive services for hereditary breast and ovarian cancer in the Czech Republic. Hered. Cancer Clin. Pract. 2006;4:3–7. doi: 10.1186/1897-4287-4-1-3. PubMed DOI PMC

Co M., Liu T., Leung J. Breast Conserving Surgery for BRCA Mutation Carriers—A Systematic Review. Clin. Breast Cancer. 2020;20:e244–e250. doi: 10.1016/j.clbc.2019.07.014. PubMed DOI

Davey M.G., Davey C.M., Ryan É.J., Lowery A.J., Kerin M.J. Combined breast conservation therapy versus mastectomy for BRCA mutation carriers—A systematic review and meta-analysis. Breast. 2021;56:26–34. doi: 10.1016/j.breast.2021.02.001. PubMed DOI PMC

Mateju M., Stribrna J., Zikan M., Kleibl Z., Janatova M., Kormunda S., Novotny J., Soucek P., Petruzelka L., Pohlreich P. Population-based study of BRCA1/2 mutations: Family history based criteria identify minority of mutation carriers. Neoplasma. 2010;57:280–285. doi: 10.4149/neo_2010_03_280. PubMed DOI

Valachis A., Nearchou A.D., Lind P. Surgical management of breast cancer in BRCA-mutation carriers: A systematic review and meta-analysis. Breast Cancer Res. Treat. 2014;144:443–455. doi: 10.1007/s10549-014-2890-1. PubMed DOI

Nagura N., Hayashi N., Takei J., Yoshida A., Ochi T., Iwahira Y., Yamauchi H. Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers. Breast Cancer (Tokyo Jpn.) 2020;27:70–76. doi: 10.1007/s12282-019-00995-y. PubMed DOI

Yamamoto D., Tanaka Y., Tsubota Y., Sueoka N., Endo K., Ogura T., Nagumo Y., Kwon A.H. Immediate breast reconstruction for breast cancer. Gan To Kagaku Ryoho = Jpn. J. Cancer Chemother. 2014;41:1892–1894. PubMed

Ballard T.N.S., Zhong L., Momoh A.O., Chung K.C., Waljee J.F. Improved Rates of Immediate Breast Reconstruction at Safety Net Hospitals. Plast. Reconstr. Surg. 2017;140:1–10. doi: 10.1097/PRS.0000000000003412. PubMed DOI

Ventruba T., Brančíková D., Ventruba P., Minář L., Felsinger M., Vomela J. Breast reconstruction in patients with BRCA mutation and breast cancer- our approach. Ceska Gynek. 2021;86:374–380. doi: 10.48095/cccg2021374. PubMed DOI

Coufal O., Gabrielová L., Justan I., Zapletal O., Selingerová I., Krsička P. Breast cancer patient satisfaction with immediate two-stage implant-based breast reconstruction. Klin. Onkol. 2014;27:353–360. doi: 10.14735/amko2014353. PubMed DOI

Schmidt J.L., Wetzel C.M., Lange K.W., Heine N., Ortmann O. Patients’ experience of breast reconstruction after mastectomy and its influence on postoperative satisfaction. Arch. Gynecol. Obstet. 2017;296:827–834. doi: 10.1007/s00404-017-4495-5. PubMed DOI

Santanelli di Pompeo F., Paolini G., Firmani G., Sorotos M. History of breast implants: Back to the future. J. Plast. Reconstr. Aesthet. Surg. 2022;32:166–177. doi: 10.1016/j.jpra.2022.02.004. PubMed DOI PMC

Dražan L., Veselý J., Hýža P., Kubek T., Foretová L., Coufal O. Chirurgická prevence karcinomu prsu pacientek s dědičným rizikem. Klin. Onkol. 2012;25:S78–S83. PubMed

Vallard A., Magné N., Guy J.B., Espenel S., Rancoule C., Diao P., Deutsch E., Rivera S., Chargari C. Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist’s point of view. Br. J. Radiol. 2019;92:20170657. doi: 10.1259/bjr.20170657. PubMed DOI PMC

Medical Tribune 24.5.2016 Onkoplastická Chirurgie Přináší do Života Kvalitu. [(accessed on 24 May 2016)]. Available online: https://www.tribune.cz/archiv/onkoplasticka-chirurgie-prinasi-do-zivota-kvalitu/

Ventruba T., Minář L., Brančíková D., Protivankova M., Ventruba P. 131P Immediate breast reconstruction in patients with BRCA mutation and breast cancer- our approach. Ann. Oncol. 2022;33((Suppl. S3)):S182. doi: 10.1016/j.annonc.2022.03.148. DOI

Ventrubová G. Master’s Thesis. Inštitút Dr. Pavla Blahu, Skalica, University of Health and Social Work St. Elizabeth; Bratislava, Slovakia: 2019. Breast Reconstruction from the Patient’s Perspective.

Cheng Y.J., Nie X.Y., Ji C.C., Lin X.X., Liu L.J., Chen X.M., Yao H., Wu S.H. Long-Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer. J. Am. Heart Assoc. 2017;6:e005633. doi: 10.1161/JAHA.117.005633. PubMed DOI PMC

Ludwig K.K., Neuner J., Butler A., Geurts J.L., Kong A.L. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am. J. Surg. 2016;212:660–669. doi: 10.1016/j.amjsurg.2016.06.010. PubMed DOI

Farhangkhoee H., Matros E., Disa J. Trends and concepts in post-mastectomy breast reconstruction. J. Surg. Oncol. 2016;113:891–894. doi: 10.1002/jso.24201. PubMed DOI PMC

Jeevan R. Reconstructive utilisation and outcomes following mastectomy surgery in women with breast cancer treated in England. Ann. R. Coll. Surg. Engl. 2019;102:110–114. doi: 10.1308/rcsann.2019.0101. PubMed DOI PMC

Hamann M., Brunnbauer M., Scheithauer H., Hamann U., Braun M., Pölcher M. Quality of life in breast cancer patients and surgical results of immediate tissue expander/implant-based breast reconstruction after mastectomy. Arch. Gynecol. Obstet. 2019;300:409–420. doi: 10.1007/s00404-019-05201-0. PubMed DOI

Yun J.H., Diaz R., Orman A.G. Breast Reconstruction and Radiation Therapy. Cancer Control. 2018;25:1073274818795489. doi: 10.1177/1073274818795489. PubMed DOI PMC

Allué Cabañuz M., Arribas Del Amo M.D., Gil Romea I., Val-Carreres Rivera M.P., Sousa Domínguez R., Güemes Sánchez A.T. Direct-to-implant breast reconstruction after neoadjuvant chemotherapy: A safe option? Cir. Esp. 2019;97:575–581. doi: 10.1016/j.ciresp.2019.07.003. PubMed DOI

Billig J., Jagsi R., Qi J., Hamill J.B., Kim H.M., Pusic A.L., Buchel E., Wilkins E.G., Momoh A.O. Should Immediate Autologous Breast Reconstruction Be Considered in Women Who Require Postmastectomy Radiation Therapy? A Prospective Analysis of Outcomes. Plast. Reconstr. Surg. 2017;139:1279–1288. doi: 10.1097/PRS.0000000000003331. PubMed DOI PMC

Nagler R.H., Gray S.W., Romantan A., Kelly B.J., DeMichele A., Armstrong K., Schwartz J.S., Hornik R.C. Differences in information seeking among breast, prostate, and colorectal cancer patients: Results from a population-based survey. Patient Educ. Couns. 2010;81:S54–S62. doi: 10.1016/j.pec.2010.09.010. PubMed DOI PMC

Durry A., Baratte A., Mathelin C., Bruant-Rodier C., Bodin F. Patients’ satisfaction after immediate breast reconstruction: Comparison between five surgical techniques. Ann. Chir. Plast. Esthet. 2019;64:217–223. doi: 10.1016/j.anplas.2018.12.002. PubMed DOI

Ventruba T., Ventruba P., Ješeta M. Immediate breast reconstruction after mastectomy from the patient’s point of view. Fertil. Steril. 2022;118:e322. doi: 10.1016/j.fertnstert.2022.09.098. DOI